Evaluation of cell-free fetal DNA to determine fetal RhD status

contributed by Revvity | 09/07/2023

Fetal Rhesus Factor D (RhD) genotyping is typically performed through non-invasive prenatal testing (NIPT) and is important in identifying RhD incompatibility between mother and child.

The FetoGnost^® Kit RHD from Ingenetix allows rapid, sensitive, and non-invasive fetal RhD genotyping of samples purified from maternal plasma of RhD-negative pregnant women, based on real-time PCR technology. In this app note, you will explore the compatibility of the FetoGnost^® Kit RHD with extracted cffDNA obtained with the chemagic™ 360 instrument using RhD-positive or -negative plasma from blood donors.

>> Download app note as a PDF

Find out more on Revvity's website here

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.